共 50 条
- [2] Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis [J]. FRONTIERS IN NEUROLOGY, 2021, 11
- [3] Anti-CD20 Disrupts Meningeal B-Cell Aggregates in a Model of Secondary Progressive Multiple Sclerosis [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (03):
- [4] Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
- [6] The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis [J]. Neurotherapeutics, 2020, 17 : 1768 - 1784
- [8] Anti-CD20 therapies for multiple sclerosis: current status and future perspectives [J]. Journal of Neurology, 2022, 269 : 1316 - 1334
- [10] Anti-CD20 Antibody Therapy for B-Cell Lymphomas [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 876 - 877